Human Genome Epidemiology Literature Finder
|
Records 1 - 11 (of 11 Records) |
| Query Trace: Pain and CYP2B6[original query] |
|---|
| Exploring rates of abnormal pharmacogenetic findings in a pain practice. Journal of pain & palliative care pharmacotherapy 2014 Mar 28 (1): 28-32. Kirsh Kenneth L, Ehlenberger Eric, Huskey Angela, Strickland Jennifer, Egan City Kathleen, Passik Steven |
| Methadone Pharmacogenetics: CYP2B6 Polymorphisms Determine Plasma Concentrations, Clearance, and Metabolism. Anesthesiology 2015 Sep . Kharasch Evan D, Regina Karen J, Blood Jane, Friedel Christi |
| CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects. British journal of clinical pharmacology 2015 Aug 80 (2): 276-84. Li Yibai, Jackson Kate A, Slon Barry, Hardy Janet R, Franco Michael, William Leeroy, Poon Peter, Coller Janet K, Hutchinson Mark R, Currow David C, Somogyi Andrew |
| Relationship between CYP2B6*6 and cold pressor pain sensitivity in opioid dependent patients on methadone maintenance therapy (MMT). Drug and alcohol dependence 2016 Aug 165 143-50. Zahari Zalina, Lee Chee Siong, Ibrahim Muslih Abdulkarim, Musa Nurfadhlina, Mohd Yasin Mohd Azhar, Lee Yeong Yeh, Tan Soo Choon, Mohamad Nasir, Ismail Rus |
| Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain. Fundamental & clinical pharmacology 2016 Apr 30 (2): 153-61. de Moraes Natália V, Lauretti Gabriela R, Coelho Eduardo B, Godoy Ana Leonor P C, Neves Daniel V, Lanchote Vera |
| A brief review of the genetics and pharmacogenetics of opioid use disorders. Dialogues in clinical neuroscience 2018 1 19 (3): 229-236. Berrettini Wa |
| Impact of protocol change on individual factors related to course of adverse reactions to chemotherapy for breast cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2019 May . Paula Daniela Polessa, do Brasil Costa Vanessa I, Jorge Rosane V, Nobre Flávio |
| Dexketoprofen Pharmacokinetics is not Significantly Altered by Genetic Polymorphism. Frontiers in pharmacology 2021 5 12 660639. Mejía-Abril Gina, Zubiaur Pablo, Navares-Gómez Marcos, Villapalos-García Gonzalo, Román Manuel, Ochoa Dolores, Abad-Santos Francis |
| Dataset of the first report of pharmacogenomics profiling in an outpatient spine setting. Data in brief 2021 3 35 106832. Cottrill Ethan, Pennington Zach, Lai Chun Wan Jeffrey, Ehresman Jeff, Jiang Bowen, Ahmed A Karim, Zhu Alex, Perdomo-Pantoja Alexander, Sciubba Daniel M, Witham Timothy, Lee Chun Hin, MacDonald Kevin, Theodore Nichol |
| Effect of common OPRM1, COMT, SLC6A4, ABCB1, and CYP2B6 polymorphisms on perioperative analgesic and propofol demands on patients subjected to thyroidectomy surgery. Pharmacological reports : PR 2023 2 . Soultati Ioanna, Ntenti Charikleia, Tsaousi Georgia, Pourzitaki Chryssa, Gkinas Dimitris, Thomaidou Evanthia, Alexandrakis Spiros, Papavramidis Theodosios, Goulas Anton |
| Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy. Clinical pharmacology and therapeutics 2024 6 . Katherine M Robinson, Seenae Eum, Zeruesenay Desta, Rachel F Tyndale, Andrea Gaedigk, Richard C Crist, Cyrine E Haidar, Alan L Myers, Caroline F Samer, Andrew A Somogyi, Pablo Zubiaur, Otito F Iwuchukwu, Michelle Whirl-Carrillo, Teri E Klein, Kelly E Caudle, Roseann S Donnelly, Evan D Kharas |
- Page last reviewed:Feb 1, 2024
- Content source: